Literature DB >> 17096086

Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonism.

Michael S Cowen1, Elena Krstew, Andrew J Lawrence.   

Abstract

RATIONALE: The development of mouse models of ethanol consumption and ethanol-seeking behavior is of particular importance in understanding the underlying mechanisms of drug abuse because these models can enable an analysis of an effect of specific genotype on drug-seeking behavior and the interaction of potential therapeutics with genotype. However, there are some limitations with present models, notably the inability to examine appetitive and consummatory behavior separately.
MATERIALS AND METHODS: In the present study, C57BL/6 mice were trained to self-administer 10% ethanol in a modified operant protocol that allowed a clear delineation of consummatory and appetitive phases. The utility of this procedure was confirmed with the use of the metabotropic glutamate 5 (mGlu5) receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP).
RESULTS: Limited-access consumption during the dark phase of the light-dark cycle with intermittent access (every second or third day) led to a high level of consumption by the mice. MTEP caused a dose-dependent decrease in both the consumption of ethanol and the appetitive response for ethanol. Furthermore, this effect was unrelated to any effect of MTEP on locomotor activity.
CONCLUSIONS: The model provides a useful paradigm for examining both the appetitive and consummatory phases of ethanol consumption in mice; furthermore, the data indicate mGlu5 receptors are involved in both phases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17096086     DOI: 10.1007/s00213-006-0583-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

1.  Increased ethanol self-administration in delta-opioid receptor knockout mice.

Authors:  A J Roberts; L H Gold; I Polis; J S McDonald; D Filliol; B L Kieffer; G F Koob
Journal:  Alcohol Clin Exp Res       Date:  2001-09       Impact factor: 3.455

2.  Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Authors:  M Navarro; M R Carrera; W Fratta; O Valverde; G Cossu; L Fattore; J A Chowen; R Gomez; I del Arco; M A Villanua; R Maldonado; G F Koob; F Rodriguez de Fonseca
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

3.  Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice.

Authors:  L D Middaugh; B M Kelley; C H Groseclose; E R Cuison
Journal:  Pharmacol Biochem Behav       Date:  2000-01-01       Impact factor: 3.533

4.  Initiation of ethanol self-administration in the rat using sucrose substitution in a sipper-tube procedure.

Authors:  H H Samson; A L Sharpe; C Denning
Journal:  Psychopharmacology (Berl)       Date:  1999-12       Impact factor: 4.530

5.  The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice.

Authors:  Clyde W Hodge; Michael F Miles; Amanda C Sharko; Rebekah A Stevenson; Jennie R Hillmann; Veronique Lepoutre; Joyce Besheer; Jason P Schroeder
Journal:  Psychopharmacology (Berl)       Date:  2005-11-15       Impact factor: 4.530

6.  Effects of SR141716A on ethanol and sucrose self-administration.

Authors:  C S Freedland; A L Sharpe; H H Samson; L J Porrino
Journal:  Alcohol Clin Exp Res       Date:  2001-02       Impact factor: 3.455

7.  Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP.

Authors:  Y M Lu; Z Jia; C Janus; J T Henderson; R Gerlai; J M Wojtowicz; J C Roder
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

8.  Effects of acamprosate on ethanol-seeking and self-administration in the rat.

Authors:  C L Czachowski; B H Legg; H H Samson
Journal:  Alcohol Clin Exp Res       Date:  2001-03       Impact factor: 3.455

9.  [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.

Authors:  Jeffery J Anderson; Sara P Rao; Blake Rowe; Darlene R Giracello; Greg Holtz; Deborah F Chapman; Lida Tehrani; Margaret J Bradbury; Nicholas D P Cosford; Mark A Varney
Journal:  J Pharmacol Exp Ther       Date:  2002-12       Impact factor: 4.030

10.  Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats.

Authors:  A Pilc; A Kłodzińska; P Brański; G Nowak; A Pałucha; B Szewczyk; E Tatarczyńska; E Chojnacka-Wójcik; J M Wierońska
Journal:  Neuropharmacology       Date:  2002-08       Impact factor: 5.250

View more
  31 in total

1.  mGlu receptors and drug addiction.

Authors:  Richard M Cleva; M Foster Olive
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-20

Review 2.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

3.  Metabotropic Glutamate Receptors in Alcohol Use Disorder: Physiology, Plasticity, and Promising Pharmacotherapies.

Authors:  Max E Joffe; Samuel W Centanni; Anel A Jaramillo; Danny G Winder; P Jeffrey Conn
Journal:  ACS Chem Neurosci       Date:  2018-06-08       Impact factor: 4.418

Review 4.  Metabotropic glutamate receptor ligands as potential therapeutics for addiction.

Authors:  M Foster Olive
Journal:  Curr Drug Abuse Rev       Date:  2009-01

5.  Nonselective suppression of operant ethanol and sucrose self-administration by the mGluR7 positive allosteric modulator AMN082.

Authors:  Michael C Salling; Sara Faccidomo; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2008-06-14       Impact factor: 3.533

6.  mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats.

Authors:  Justin T Gass; Megan P H Osborne; Noreen L Watson; Jordan L Brown; M Foster Olive
Journal:  Neuropsychopharmacology       Date:  2008-09-17       Impact factor: 7.853

Review 7.  Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.

Authors:  Sunil Goodwani; Hannah Saternos; Fawaz Alasmari; Youssef Sari
Journal:  Neurosci Biobehav Rev       Date:  2017-02-24       Impact factor: 8.989

Review 8.  Future pharmacological treatments for substance use disorders.

Authors:  Ariadna Forray; Mehmet Sofuoglu
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

9.  The Effect of mGluR5 Antagonism During Binge Drinkingon Subsequent Ethanol Intake in C57BL/6J Mice: Sex- and Age-Induced Differences.

Authors:  Debra K Cozzoli; Moriah N Strong-Kaufman; Michelle A Tanchuck; Joel G Hashimoto; Kristine M Wiren; Deborah A Finn
Journal:  Alcohol Clin Exp Res       Date:  2013-10-29       Impact factor: 3.455

10.  Differential modulation of ethanol-induced sedation and hypnosis by metabotropic glutamate receptor antagonists in C57BL/6J mice.

Authors:  Amanda C Sharko; Clyde W Hodge
Journal:  Alcohol Clin Exp Res       Date:  2007-12-07       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.